Literature DB >> 19519840

Distribution of emm types among group A streptococcal isolates from Serbia.

V Mijac1, L Ranin, M Marković, C Heeg, R R Reinert, N Opavski.   

Abstract

This is the first study concerning the molecular epidemiology of group A streptococcus in Serbia and includes 145 isolates from patients with various infections during the period 2001-2007. The emm types, superantigen profile and susceptibility pattern were determined. Among 31 emm types identified, the most prevalent were emm 6, emm 12, emm 1, and emm 58. All isolates showed uniform antimicrobial susceptibility to all tested antibiotics, with the exception of tetracycline and erythromycin (41% and 0.7% resistant strains, respectively). Significant heterogeneity of emm types was found, with a high frequency of emm 6 and emm 58, as well as a considerable prevalence of tetracycline resistance, and a low level of macrolide resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519840     DOI: 10.1111/j.1469-0691.2009.02823.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

1.  Distribution of emm types in invasive and non-invasive group A and G streptococci.

Authors:  S Vähäkuopus; R Vuento; T Siljander; J Syrjänen; J Vuopio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-16       Impact factor: 3.267

2.  Hospital acquired invasive group A streptococcus infections.

Authors:  Ayse Erbay
Journal:  Indian J Crit Care Med       Date:  2014-02

3.  Trends in macrolide resistance of respiratory tract pathogens in the paediatric population in Serbia from 2004 to 2009.

Authors:  V Mijac; N Opavski; M Markovic; I Gajic; Z Vasiljevic; T Sipetic; M Bajcetic
Journal:  Epidemiol Infect       Date:  2014-05-09       Impact factor: 4.434

4.  Streptococcus pyogenes Causing Skin and Soft Tissue Infections Are Enriched in the Recently Emerged emm89 Clade 3 and Are Not Associated With Abrogation of CovRS.

Authors:  Catarina Pato; José Melo-Cristino; Mario Ramirez; Ana Friães
Journal:  Front Microbiol       Date:  2018-10-09       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.